Sugentech Inc. (KOSDAQ:253840)

Market Cap	106.26B +25.9%
Revenue (ttm)	9.42B -6.7%
Net Income	-23.31B
EPS	-1,525.00
Shares Out	15.29M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,959,331
Average Volume	6,061,055
Open	6,770.00
Previous Close	6,950.00
Day's Range	6,380.00 - 7,440.00
52-Week Range	4,310.00 - 9,390.00
Beta	n/a
RSI	61.10
Earnings Date	May 21, 2026

About Sugentech

Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers Multiplex BLOT disease diagnostic devices, such as immunoblot processor, semi and full automation, and molecular diagnostic systems, as well as test items; and self-testing products, including digital ovulation, pregnancy test, and early sign pregnancy test, as well as mobile testing products. It also provides point of care testing analyzers and test ...

• Industry: Medical - Specialties
• Sector: Healthcare
• Founded: 2011
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 253840

Financial Performance

In 2025, Sugentech's revenue was 9.42 billion, a decrease of -6.74% compared to the previous year's 10.10 billion. Losses were -23.31 billion, 53.5% more than in 2024.